Patient preference is leaning towards Eli Lilly’s weight loss drugs, says Guggenheim’s Fernandez
Seamus Fernandez, Guggenheim managing director, joins 'Power Lunch' to discuss the battle between Novo Nordisk and Eli Lilly. For access ...
Sunday, August 16, 2026
Tag: Guggenheims
Launch of Wegovy pill is core to Novo Nordisk’s growth, says Guggenheim’s Seamus Fernandez
Guggenheim's Seamus Fernandez joins 'Fast Money' to talk Novo Nordisk getting Wegovy pill approved. source
North America was really good for Nike despite weak China sales, says Guggenheim’s Simeon Siegel
Simeon Siegel, Guggenheim Securities consumer equity research analyst, joins 'Power Lunch' to discuss what the market's missing with Nike, what's ...
Stay updated with DeFi Daily, your trusted source for the latest news, insights, and analysis in finance and cryptocurrency. Explore breaking news, expert analysis, market data, and educational resources to navigate the world of decentralized finance.